Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVO) Cash & Equivalents (2021 - 2024)

Historic Cash & Equivalents for Alvotech (ALVO) over the last 6 years, with Q3 2025 value amounting to $51.4 million.

  • Alvotech's Cash & Equivalents fell 5651.79% to $51.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.4 million, marking a year-over-year decrease of 5651.79%. This contributed to the annual value of $11.2 million for FY2024, which is 0.0% changed from last year.
  • Per Alvotech's latest filing, its Cash & Equivalents stood at $51.4 million for Q3 2025, which was down 5651.79% from $151.5 million recorded in Q2 2025.
  • In the past 5 years, Alvotech's Cash & Equivalents ranged from a high of $151.5 million in Q2 2025 and a low of $11.2 million during Q3 2023
  • Over the past 5 years, Alvotech's median Cash & Equivalents value was $51.4 million (recorded in 2024), while the average stood at $47.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 8154.83% in 2024, then soared by 125746.17% in 2025.
  • Alvotech's Cash & Equivalents (Quarter) stood at $17.6 million in 2021, then changed by 0.0% to $17.6 million in 2022, then tumbled by 36.45% to $11.2 million in 2023, then surged by 360.95% to $51.4 million in 2024, then changed by 0.0% to $51.4 million in 2025.
  • Its last three reported values are $51.4 million in Q3 2025, $151.5 million for Q2 2025, and $51.4 million during Q1 2025.